At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EUDA EUDA Health Holdings Limited
Closed 06-04 16:00:00 EDT
16.31
-0.38
-2.29%
盘后16.31
+0.000.00%
16:10 EDT
High17.08Low16.00Vol8.74K
Open17.08D1 Closing16.69Amplitude6.47%
Mkt Cap48.84MTradable Cap33.54MTotal Shares2.99M
T/O143.33KT/O Rate0.42%Tradable Shares2.06M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

EUDA Health regains Nasdaq compliance
TIPRANKS  ·  06-01
EUDA Health regains Nasdaq compliance
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
GlobeNewswire  ·  06-01
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
Euda Health regains Nasdaq compliance after market value falls below $35 million threshold
Reuters  ·  06-01
Euda Health regains Nasdaq compliance after market value falls below $35 million threshold
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
GlobeNewswire  ·  06-01
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
EUDA Health Holdings Ltd trading resumes
TIPRANKS  ·  05-07
EUDA Health Holdings Ltd trading resumes
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM
Reuters  ·  05-06
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:52 AM
Reuters  ·  04-29
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:52 AM
Euda Health FY25 net loss narrows 82% to $2.77 million; revenue rises 70% to $6.82 million
Reuters  ·  04-29
Euda Health FY25 net loss narrows 82% to $2.77 million; revenue rises 70% to $6.82 million
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
GlobeNewswire  ·  04-28
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
EUDA Health Holdings Ltd trading halted, volatility trading pause
TIPRANKS  ·  04-27
EUDA Health Holdings Ltd trading halted, volatility trading pause
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM
Reuters  ·  04-27
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM
EUDA Health receives listing noncompliance notice from Nasdaq
TIPRANKS  ·  04-27
EUDA Health receives listing noncompliance notice from Nasdaq
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
GlobeNewswire  ·  04-27
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
EUDA Health Holdings Ltd trading halted, volatility trading pause
TIPRANKS  ·  04-23
EUDA Health Holdings Ltd trading halted, volatility trading pause
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
Reuters  ·  04-23
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
Reuters  ·  03-21
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
EUDA Health Holdings Ltd trading halted, news pending
TIPRANKS  ·  03-21
EUDA Health Holdings Ltd trading halted, news pending
BRIEF-EUDA Announces Reverse Stock Split Of Its Ordinary Shares
Reuters  ·  03-19
BRIEF-EUDA Announces Reverse Stock Split Of Its Ordinary Shares
Euda Health Holdings to execute 1-for-20 reverse stock split on March 23, 2026
Reuters  ·  03-19
Euda Health Holdings to execute 1-for-20 reverse stock split on March 23, 2026
EUDA Health Holdings Ltd: Will Implement a Reverse Stock Split of Its Ordinary Shares at a Ratio of 1-for-20
THOMSON REUTERS  ·  03-19
EUDA Health Holdings Ltd: Will Implement a Reverse Stock Split of Its Ordinary Shares at a Ratio of 1-for-20

Introduction

Company Name.
EUDA Health Holdings Limited
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--